These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2976766)

  • 1. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?
    Cohen MP
    J Diabet Complications; 1988; 2(4):214-7. PubMed ID: 2976766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications.
    Sensi M; Pricci F; Andreani D; Di Mario U
    Diabetes Res; 1991 Jan; 16(1):1-9. PubMed ID: 1818791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aging mechanisms of proteins].
    Gillery P; Monboisse JC; Maquart FX; Borel JP
    Diabete Metab; 1991; 17(1):1-16. PubMed ID: 1651260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes, advanced glycation endproducts and vascular disease.
    Wautier JL; Guillausseau PJ
    Vasc Med; 1998; 3(2):131-7. PubMed ID: 9796076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease.
    Brownlee M; Cerami A; Vlassara H
    Diabetes Metab Rev; 1988 Aug; 4(5):437-51. PubMed ID: 2850143
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between plasma glycation with membrane modification, oxidative stress and expression of glucose trasporter-1 in type 2 diabetes patients with vascular complications.
    Adeshara KA; Diwan AG; Jagtap TR; Advani K; Siddiqui A; Tupe RS
    J Diabetes Complications; 2017 Feb; 31(2):439-448. PubMed ID: 27884659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility.
    Mott JD; Khalifah RG; Nagase H; Shield CF; Hudson JK; Hudson BG
    Kidney Int; 1997 Nov; 52(5):1302-12. PubMed ID: 9350653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of glycation process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus].
    Sternberg M; Urios P; Grigorova-Borsos AM
    C R Seances Soc Biol Fil; 1995; 189(6):967-85. PubMed ID: 8763028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of delta-gluconolactone, an oxidised analogue of glucose, on the nonenzymatic glycation of human and rat haemoglobin.
    Lindsay RM; Smith W; Lee WK; Dominiczak MH; Baird JD
    Clin Chim Acta; 1997 Jul; 263(2):239-47. PubMed ID: 9246427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of diabetic microangiopathy].
    Caimi G; Lo Presti R
    Minerva Endocrinol; 1993 Jun; 18(2):49-68. PubMed ID: 8289751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
    Yamagishi S
    Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
    Aubert CE; Michel PL; Gillery P; Jaisson S; Fonfrede M; Morel F; Hartemann A; Bourron O
    Diabetes Metab Res Rev; 2014 Nov; 30(8):679-85. PubMed ID: 24449227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
    Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
    J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Label-free nonenzymatic glycation monitoring of collagen scaffolds in type 2 diabetic mice by confocal Raman microspectroscopy.
    Shi P; Liu H; Deng X; Jin Y; Wang Q; Liu H; Chen M; Han X
    J Biomed Opt; 2015 Feb; 20(2):27002. PubMed ID: 25671672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiologic aspects of diabetic angiopathy].
    Wautier JL; Wautier MP
    Diabetes Metab; 1999 Jun; 25 Suppl 3():21-6. PubMed ID: 10421989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors.
    Vlassara H; Bucala R
    Diabetes; 1996 Jul; 45 Suppl 3():S65-6. PubMed ID: 8674896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic cardiomyopathy: the significance of creatine.
    Guichard P; Burkhardt JE; Seidler NW
    Med Hypotheses; 1995 Jul; 45(1):41-4. PubMed ID: 8524176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat tissue collagen modified by advanced glycation: correlation with duration of diabetes and glycemic control.
    Turk Z; Misur I; Turk N; Benko B
    Clin Chem Lab Med; 1999 Aug; 37(8):813-20. PubMed ID: 10536930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Pathogenesis of diabetic microangiopathy"--its past, present and future horizon.
    Jali MV
    J Assoc Physicians India; 1985 Dec; 33(12):803-9. PubMed ID: 3915501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.